15 Practice-Changing Updates for Physicians 2025–26 | Dr Parag Rana | META MEDICON 2026

What changed in clinical practice during 2025–26, and which updates should physicians start applying in day-to-day practice? In this rapid, clinically focused lecture from META MEDICON 2026, Dr Parag Rana, Vadodara, reviews major practice-changing developments across hypertension, cardiology, diabetes, nephrology, hepatology, infectious diseases, pulmonology and neurology. The presentation begins with important updates in cardiovascular medicine, including the shift away from the term “hypertensive urgency” toward severe asymptomatic hypertension, greater emphasis on gradual blood-pressure reduction in patients without acute target-organ damage, screening for primary aldosteronism in resistant hypertension, once-in-a-lifetime lipoprotein(a) assessment, and evolving approaches to cardiovascular risk estimation. Dr Rana then discusses developments in diabetes and cardiometabolic care, including the role of tirzepatide in obesity-associated obstructive sleep apnea, wider use of continuous glucose monitoring, early combination therapy in type 2 diabetes, and strategies for patients who are statin-intolerant. The nephrology section covers SGLT2 inhibitors in non-diabetic CKD, semaglutide and kidney outcomes, finerenone, and the evolving multi-drug framework for diabetic kidney disease. The hepatology discussion includes MASLD/MASH terminology, resmetirom, changing approaches to hepatitis C treatment and newer acid-suppression strategies for H. pylori treatment. The lecture also touches on adult vaccination, antimicrobial choices, severe asthma biologics and emerging biomarkers in cognitive impairment, making it a broad update for physicians who want a concise overview of recent changes across internal medicine. Key topics covered: Severe asymptomatic hypertension vs “hypertensive urgency” When aggressive BP reduction should be avoided Primary aldosteronism screening in resistant hypertension Potassium-enriched salt substitutes Lipoprotein(a) screening PREVENT cardiovascular risk assessment Tirzepatide and obstructive sleep apnea CGM in type 2 diabetes Early combination therapy in diabetes Bempedoic acid in statin intolerance SGLT2 inhibitors in non-diabetic CKD Semaglutide and kidney outcomes Finerenone and cardiorenal protection Updated diabetic kidney disease framework MASLD/MASH updates Resmetirom in MASH HCV treatment without routine genotyping in selected settings H. pylori treatment updates Adult vaccination Severe asthma biologics Emerging Alzheimer’s biomarkers Speaker: Dr Parag Rana, Vadodara Topic: 15 Practice-Changing Updates for Physicians – 2025–26 Session: Practice-Changing Advances in Diabetes & Internal Medicine Conference: META MEDICON 2026 – APICON–CCDSICON Gujarat Chapter 2026 Date: 1 August 2026 Venue: Waves Club, Vadodara This video is intended for medical education and professional academic discussion. As recommendations and approvals evolve, viewers should refer to current guidelines, prescribing information and individualized clinical judgement before applying any update in practice. #InternalMedicine #ClinicalUpdates #Hypertension #Diabetes #CKD #MASLD #CardiometabolicMedicine #MedicalGuidelines #PhysicianEducation #MedicalEducation #MetaMedicon2026 #IDCM